Has CSL been growing its dividend?

Is the biotech giant still increasing its dividends in a post-COVID world?

| More on:
A health professional wearing a stethoscope and scrubs shrugs with uncertainty.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The CSL share price has been stuck in the mud for years now
  • It's a different story to the last decade, which saw the company grow massively
  • But even though CSL shares aren't growing in value, we check what's happening with the company's dividends

The recent performance of the CSL Limited (ASX: CSL) share price might have brought some disappointment for ASX investors. Shares of this ASX 200 healthcare giant have been stuck in the mud for a while now. The company last saw an all-time high back in February 2020 – right before the onset of the coronavirus pandemic.

Back then, CSL shares reached as high as $336 a share. But that was more than two years ago now. CSL has rarely even approached those levels since. It climbed above the $300 mark a few times last year. But, on each occasion, that didn't end up lasting too long. CSL hasn't been above $300 in 2022 at all. Today, it's finished at $274.03, up 0.38%.

So CSL is trading at the same level it was in November 2019. The company's stagnant performance since then is a far cry from the glory days the years prior which typically saw CSL jump by double-digits every year.

But what of the company's dividends? Since the CSL share price has been so lethargic, dividend returns have had to keep investors placated. So has the CSL dividend been growing in recent years?

Has the CSL dividend been growing?

Well, sort of. In most cases, it's fairly easy to determine this kind of question. But CSL makes things just a little more complicated than usual. That's because this company pay its dividends in US dollars. And in greenback terms, yes, CSL has been increasing its dividend very consistently.

In 2021, the healthcare company paid out a total of US$2.22 in dividends per share, consisting of an interim dividend of US$1.04 and a final dividend of US$1.18.

That was a healthy increase on the US$2.02 in dividends per share CSL doled out in 2020. It also represents the latest annual dividend increase (in US dollar terms) in what is now almost a ten-year streak.

However, there is a caveat. In Australian dollar terms, CSL's dividends have not had such a nice, linear streak of dividend growth. Although CSL increased its dividends from US$2.02 to US$2.22 between 2020 and 2021, it was a different story in Australian dollar terms.

Due to currency fluctuations, CSL investors did not receive a dividend increase in 2021. The company paid out a total of $2.941 in dividends per share in 2020, but only $2.939 in 2021.

Still, CSL has shown an impressive history of delivering a growing dividend to ASX investors over many years. At today's pricing, CSL offers a trailing dividend yield of 0.95%.

Motley Fool contributor Sebastian Bowen has positions in CSL Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Why 4DMedical shares are jumping 14% today

4DMedical shares climb on a new CFO appointment as investors focus on US expansion and rising use of its lung…

Read more »

A business woman flexes her muscles overlooking a city scape below.
Healthcare Shares

Why I plan to buy this incredible ASX 200 stock in 2026

A 33% pullback has put Pro Medicus back in focus. Here’s why I’m preparing to buy its shares in 2026.

Read more »

research with microscope
Healthcare Shares

This ASX healthcare stock just changed its debt. Here's why it matters

Shares in Mesoblast edge higher after the company announces a major change to its debt and funding structure.

Read more »

stock growth chart
Healthcare Shares

Will CSL shares crash again in 2026?

CSL shares have fallen almost 40% in 2025. Investors are now asking if the worst is already behind the stock.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Here's the dividend forecast out to 2030 for Sigma shares

This business could pay healthy dividends in the coming years…

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Mayne Pharma signals short-term pain as it resets for growth

It has been a turbulent year for Mayne Pharma after the terminated takeover bid by US company Cosette Pharmaceuticals.

Read more »

A man packs up a box of belongings at his desk as he prepares to leave the office.
Healthcare Shares

Regis Healthcare shares down 2% as CEO resigns

Dr Mellors will step down as CEO after more than six years in the role.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Telix shares storm higher on big US and China news

Let's see why this biotech is getting attention on Monday.

Read more »